文献速递心律失常瓣膜病与结构性心脏病

终末期肾病长期透析房颤患者左心耳封堵的安全性与有效性

[Safety and effectiveness of left atrial appendage occlusion in patients with atrial fibrillation and end-stage renal disease undergoing long-term hemodialysis].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2021-01-01

北京安贞医院回顾性纳入2017年3月至2021年3月6例房颤合并终末期肾病长期透析并接受左心耳封堵术的患者,4例行单纯封堵、2例同期行导管消融。6例均成功置入Watchman封堵器,围术期无严重并发症,随访22.0(12.0,32.0)个月无血栓栓塞或大出血事件,2例死亡。

要点

  • 6例长期透析的终末期肾病合并房颤患者均成功置入Watchman封堵器,围术期无严重并发症。
  • 术后45或60 d经食道超声未见封堵器相关血栓及残余分流。
  • 随访22.0(12.0,32.0)个月无血栓栓塞或大出血事件,但2例死亡。

核心结论

  • 长期透析的终末期肾病合并房颤患者行左心耳封堵术预防血栓栓塞可能具有良好的安全性和有效性,但尚需更大样本量研究证实。

研究设计与样本

  • 北京安贞医院心内科回顾性研究,纳入2017年3月至2021年3月房颤合并终末期肾病长期透析并接受左心耳封堵术的患者6例。
  • 4例患者行左心耳封堵术,2例患者同期行房颤导管消融;记录围术期治疗及严重并发症。

主要发现

  • 6例患者年龄(66.7±17.0)岁,男性5例(5/6),阵发性房颤4例(4/6),持续性房颤2例(2/6)。
  • CHA2DS2-VASc评分(4.8±1.5)分,HAS-BLED评分(3.5±1.4)分,持续透析2.6(1.1,8.3)年。
  • 6例均成功置入Watchman封堵器,围术期未发生血栓栓塞或出血等严重并发症;术后45或60 d经食道超声均未见封堵器相关血栓形成及残余分流。
  • 随访22.0(12.0,32.0)个月无血栓栓塞或大出血事件,1例出现皮下出血;2例死亡,1例术后32个月猝死,1例术后32个月死于心力衰竭。

临床怎么用

  • 对长期透析的终末期肾病合并房颤、卒中及出血风险高的患者,左心耳封堵术可作为预防血栓栓塞的候选治疗选择。
  • 术后需按计划行经食道超声复查并长期随访血栓栓塞、出血及生存情况。

局限性

  • 回顾性单中心研究,样本量仅6例,结论需进一步更大样本量研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the safety and effectiveness of left atrial appendage occlusion (LAAO) in patients with atrial fibrillation and end-stage renal disease undergoing long-term hemodialysis. Methods: Six patients with AF and end-stage renal disease(ESRD)on long term hemodialysis who underwent LAAO from March 2017 to March 2021 in Beijing Anzhen Hospital were enrolled. Baseline characteristics such as age, sex, types of arrhythmia, stroke and bleeding score, and continuous dialysis time were collected. Four patients underwent LAAO, two patients underwent the combined procedure of catheter ablation and LAAO. Perioperative treatment and serious complications were recorded. Transesophageal echocardiography was repeated at 45 days and 60 days after the procedure. Telephone follow-up was conducted at 3, 6 and 12 months after the procedure, and every 6 months thereafter. Thromboembolism and major bleeding events and survival were evaluated. Results: The average age was (66.7±17.0) years old, and 5 were male (5/6). There were 4 patients with paroxysmal AF (4/6), and 2 patients with persistent AF (2/6). The mean CHA2DS2-VASc score was (4.8±1.5), and the HAS-BLED score was (3.5±1.4). The duration of hemodialysis was 2.6 (1.1, 8.3) years. Successfully Watchman implantation was achieved in all patients. There were no severe perioperative complications, and no device related thrombosis or leaks were observed by transesophageal echocardiography. During a mean of 22.0 (12.0, 32.0) months follow-up, there was no thromboembolism or major bleeding events. A total of 2 patients died, one from sudden cardiac death, and another one from heart failure. Conclusions: LAAO may be a safe and effective therapeutic option for prevention of thromboembolism in patients with atrial fibrillation and end-stage renal disease undergoing long-term hemodialysis, further studies with larger patient cohort are needed to confirm our results. 目的: 初步评估长期透析的终末期肾病合并心房颤动(房颤)患者行左心耳封堵术的安全性和有效性。 方法: 回顾性地选取北京安贞医院心内科2017年3月至2021年3月房颤合并终末期肾病长期透析并接受左心耳封堵术治疗的患者6例,收集患者的年龄、性别、心律失常类型、卒中及出血评分、持续透析时间等基线临床数据。4例患者行左心耳封堵术,2例患者同期行房颤导管消融。记录围术期治疗情况及严重并发症。术后45或60 d复查经食道超声心动图,术后3、6、12个月进行常规电话或门诊随访,此后每6个月随访1次,分析随访期间患者血栓栓塞、大出血事件发生率及生存情况。 结果: 纳入的6例患者年龄(66.7±17.0)岁,男性5例(5/6),阵发性房颤4例(4/6),持续性房颤2例(2/6),CHA2DS2-VASc评分为(4.8±1.5)分,HAS-BLED评分为(3.5±1.4)分,持续透析2.6(1.1,8.3)年。6例患者均成功置入Watchman封堵器,围术期均未发生血栓栓塞或出血等严重并发症。术后45或60 d复查经食道超声心动图均未见封堵器相关血栓形成及残余分流。随访22.0(12.0,32.0)个月,无血栓栓塞或大出血事件发生,1例患者出现皮下出血。2例患者死亡,1例术后32个月猝死,1例术后32个月死于心力衰竭。 结论: 长期透析的终末期肾病合并房颤的患者行左心耳封堵术预防血栓栓塞可能具有良好的安全性和有效性,但该结论尚需进一步更大样本量的研究证实。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Dai WL, Yao KX, Jiang C, et al. [Safety and effectiveness of left atrial appendage occlusion in patients with atrial fibrillation and end-stage renal disease undergoing long-term hemodialysis]. Zhonghua Xin Xue Guan Bing Za Zhi. 2021. PMID: 34530595. doi:10.3760/cma.j.cn112148-20210608-00487

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。